EUVIMEDEUVIMED entdecken
Crossref

The Challenge of Treating the Severest Forms of Chronic Noninfectious Posterior and Panuveitis

Christoph Spartalis, Nicole Stübiger, Martin S Spitzer, Udo Bartsch, Yevgeniya Atiskova iD

Klinische Monatsblätter für Augenheilkunde · 01.12.2024 · 241 (12) · 1349-1360

DOI: 10.1055/a-2074-9102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.12.2024. Verfasst von Christoph Spartalis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Hanusch Hospital, Wien, Austria. Hauptthemen laut MEDLINE: Panuveitis, Immunosuppressive Agents, Visual Acuity. Die Arbeit nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Noninfectious posterior and panuveitis may exhibit a chronic relapsing clinical course and are challenging to treat. Most affected patients are continuously treated with systemic immunosuppressive therapy, which is potentially associated with significant adverse side effects.

Methods

A cohort of 18 patients presenting with severe noninfectious posterior or panuveitis were evaluated with respect to the clinical course of the disease, with particular focus on best-corrected visual acuity (BCVA), treatment duration, remission rates, reported negative side effects, and the necessity for switching medication.

Results

The mean follow-up was 27.8 months. Although BCVA improved significantly, complete or partial remission was observed in only 66.7% of patients. Of the patients, 72.2% underwent a change in medical treatment due to either adverse events or inefficacy of medication.

Conclusion

Despite new immunosuppressive therapies, effective treatment of severe noninfectious posterior and panuveitis remains a major challenge. We discuss the urgent need for novel treatment strategies in order to prevent systemic adverse effects, and to improve visual outcome and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PanuveitisImmunosuppressive AgentsVisual AcuityHumansMaleFemaleMiddle AgedTreatment OutcomeChronic DiseaseAdultAgedUveitis, PosteriorVision DisordersYoung Adult

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Ophthalmology, Hanusch Hospital, Wien, Austria.
  • Ophthalmology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Yevgeniya Atiskova

Zitieren

APA

Spartalis, C., Stübiger, N., Spitzer, M. S., Bartsch, U., & Atiskova, Y. (2024). The Challenge of Treating the Severest Forms of Chronic Noninfectious Posterior and Panuveitis. Klinische Monatsblätter für Augenheilkunde, 241(12), 1349-1360. https://doi.org/10.1055/a-2074-9102

Vancouver

Spartalis C, Stübiger N, Spitzer MS, Bartsch U, Atiskova Y. The Challenge of Treating the Severest Forms of Chronic Noninfectious Posterior and Panuveitis. Klinische Monatsblätter für Augenheilkunde. 2024;241(12):1349-1360. doi:10.1055/a-2074-9102

BibTeX
@article{Spartalis2024,
  author = {Spartalis, Christoph and Stübiger, Nicole and Spitzer, Martin S and Bartsch, Udo and Atiskova, Yevgeniya},
  title = {The Challenge of Treating the Severest Forms of Chronic Noninfectious Posterior and Panuveitis},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2024},
  volume = {241},
  number = {12},
  pages = {1349--1360},
  doi = {10.1055/a-2074-9102}
}
Kostenlos starten →